AU4356689A - Process for the preparation of 4-o-alkylrhodomycins - Google Patents

Process for the preparation of 4-o-alkylrhodomycins

Info

Publication number
AU4356689A
AU4356689A AU43566/89A AU4356689A AU4356689A AU 4356689 A AU4356689 A AU 4356689A AU 43566/89 A AU43566/89 A AU 43566/89A AU 4356689 A AU4356689 A AU 4356689A AU 4356689 A AU4356689 A AU 4356689A
Authority
AU
Australia
Prior art keywords
alkyl
group
acyl
protective group
rhodomycins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43566/89A
Inventor
Cenek Kolar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU4356689A publication Critical patent/AU4356689A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/40Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/461,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A process for preparing 4-O-alkyl-rhodomycins of the formula I <IMAGE> in which R<1> is H, C1-C4-alkyl or an acyl protective group, R<2> is OH, COOCH3, O-Si(C1-C4-alkyl)3 or an O-acyl protective group, where acyl is acetyl, mono-, di- or trihalogenoacetyl with fluorine or chorine as halogen, benzoyl or p-nitrobenzoyl, R<3> is C1-C4-alkyl, R<4> is H or R<4> and R<5> together are a tetraisopropyldisiloxane-1,3-diyl protective group, R<5> is H or a glycosyl radical of the formula II <IMAGE> in which R<6> is OH, acetyloxy, NHCOCF3, NH2, a mono- or di-C1-C4-alkyl amino group or a 4-morpholinyl group, R<7> is H, OH, an acetyloxy, trifluoroacetyloxy or p-nitrobenzoyloxy group, and the use thereof for preparing 7-O-glucosyl-rhodomycins which, by reason of their cytostatic activity, are suitable for the treatment of cancers, are described.
AU43566/89A 1988-10-22 1989-10-20 Process for the preparation of 4-o-alkylrhodomycins Abandoned AU4356689A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3836122 1988-10-22
DE3836122A DE3836122A1 (en) 1988-10-22 1988-10-22 METHOD FOR PRODUCING 4-0-ALKYL RHODOMYCINES

Publications (1)

Publication Number Publication Date
AU4356689A true AU4356689A (en) 1990-04-26

Family

ID=6365756

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43566/89A Abandoned AU4356689A (en) 1988-10-22 1989-10-20 Process for the preparation of 4-o-alkylrhodomycins

Country Status (9)

Country Link
EP (1) EP0365973B1 (en)
JP (1) JPH02164840A (en)
KR (1) KR900006358A (en)
AT (1) ATE98626T1 (en)
AU (1) AU4356689A (en)
CA (1) CA2001087A1 (en)
DE (2) DE3836122A1 (en)
DK (1) DK523189A (en)
PT (1) PT92031B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633671B2 (en) * 1989-12-27 1993-02-04 Behringwerke Aktiengesellschaft Process for the preparation of glycosylanthracyclinones

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3771013T (en) * 2018-03-23 2023-06-14 Tomiyama Pure Chemical Industries Ltd Electrolyte for power storage devices and nonaqueous electrolyte solution

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3641833A1 (en) * 1986-12-08 1988-06-09 Behringwerke Ag CYTOSTATICALLY EFFECTIVE ANTHRACYCLINE DERIVATIVES
DE3641835A1 (en) * 1986-12-08 1988-06-16 Behringwerke Ag CYTOSTATICALLY EFFECTIVE ANTHRACYCLINE DERIVATIVES
DE3712350A1 (en) * 1987-04-11 1988-10-20 Behringwerke Ag SEMISYNTHETIC RHODOMYCINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS CYTOSTATICS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633671B2 (en) * 1989-12-27 1993-02-04 Behringwerke Aktiengesellschaft Process for the preparation of glycosylanthracyclinones

Also Published As

Publication number Publication date
PT92031A (en) 1990-04-30
DE3836122A1 (en) 1990-05-31
EP0365973B1 (en) 1993-12-15
DK523189A (en) 1990-04-23
EP0365973A1 (en) 1990-05-02
CA2001087A1 (en) 1990-04-22
KR900006358A (en) 1990-05-08
JPH02164840A (en) 1990-06-25
DE58906440D1 (en) 1994-01-27
PT92031B (en) 1995-06-30
DK523189D0 (en) 1989-10-20
ATE98626T1 (en) 1994-01-15

Similar Documents

Publication Publication Date Title
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
HK1008020A1 (en) Glycosylated prodrugs process for their preparation and uses thereof
AU3362984A (en) Trace-labeled conjugates of metallothionein and target- seeking biologically active molecules
GR3006630T3 (en)
AU3119995A (en) Treatment of cancer using hsv mutant
IL100054A0 (en) 1,3-bis-(3-(mono-or poly-hydroxy)acylamino-5-(mono-or poly-hydroxy-alkyl)aminocarbonyl-2,4,6-triodo-benzoyl-amino)-hydroxy-or hydroxyalkyl-propanes,their methods of preparation and x-ray contrast media containing them
ZA894777B (en) New substituted sulphonamides
DE3563533D1 (en) Derivatives of glycerophosphocholine and of glycerophosphoethanol amine, their preparation and use
IE863381L (en) Antibiotics
HU913572D0 (en) Complexes containing s(+)-phenyl-alkane-acids and amino-sugars
AU6578890A (en) Nonionic x-ray contrast medium with high iodine content
AU4356689A (en) Process for the preparation of 4-o-alkylrhodomycins
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
ES8707734A1 (en) Cephalosporins, process for their preparation and their use in medicaments.
DE3572441D1 (en) Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
AU8816682A (en) 3-phenoxypropan-2-ol derivatives
AU8144687A (en) Peptides
EP0292806A3 (en) Substituted vinyl cephalosporins, process for their preparation and their use as medicines
EP0317913A3 (en) Di(meth)acrylates, process for their preparation and their use
EP0459176A3 (en) Oligophosphates with antiviral activity
IT1247900B (en) Cyclo and poly-phosphazenes containing substituents with ethylenic double bonds and process for their preparation
ES2061722T3 (en) DERIVATIVES OF FENANTRIDINE, PROCEDURE FOR ITS OBTAINING AND AGENTS FOR THE PERFORMANCE OF THE PROCEDURE.
DE3372970D1 (en) 6-alpha-methyl-prednisolone derivatives, their preparation and utilization
IT1274010B (en) Use of mifepristone for the production of endogenous alpha interferon
WO1992013072A3 (en) Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli